期刊文献+

卵巢癌术后复发的特征及相关影响因素分析

Characters and related factors of postoperative recurrence of ovarian carcinoma
下载PDF
导出
摘要 目的 探讨卵巢癌术后复发的特征及相关因素,寻找预防和降低卵巢癌复发的方法。方法 回顾性分析83例卵巢癌患者的临床病理资料,对其中复发的34例进行分析,寻找复发的相关因素。结果 完全缓解的79例中,复发34例,1年内复发率最高,为61.8%;复发部位盆腔最多,占61.8%。Ⅰ、Ⅱ期复发率较Ⅲ、Ⅳ期低(P〈0.005);浆液性癌复发率较粘液性癌及其他癌高(P〈0.025)。组织低、中分化较高分化复发率高(P〈0.005)。残余病灶直径〈2cm,较≥2cm者复发率低(P〈0.005)。术后化疗0。5个疗程,较≥6个疗程者复发率高(P〈0.05)。有无大网膜转移者以及原发灶部位为单侧及双侧卵巢者之间复发率差异均无显著性(P〉0.05)。结论 卵巢癌术后1年内复发率最高;最常见复发转移部位为盆腔。复发与临床期别、病理类型、组织分化、规范肿瘤细胞减灭术及术后残余病灶的大小及术后规范化疗有关。 Objective To analyze the characters and potential factors of postoperative recurrence of ovarian carcinoma. To investigate the methods of preventing and reducing the recurrence of ovarian carcinoma. Methods The clinic - pathological features of 83 patients with ovarian carcinoma, including 34 with recurrence were analyzed retrospectively. Results Among the 79 cases achieved complete remission, 34 reeun'ed. The recurrent rate was highest within 1 year, 61.8%, and the most cornmen recurrent sites are within pelvic, 61.8%. The recurrent rate of FIGO stage Ⅰ-Ⅱ was significantly lower than that of stage Ⅲ-Ⅳ ( P 〈 0.005). The recurrent rate of serous carcinoma was higher than that of mucous or other s. the recurrent rate of poor or moder ate differentiated cancer was significantly higher than that of well differentiated ( P 〈 0.05). In cases with 〈 2 em residue, the recurrent rate was significantly lower than those with≥2 cm residue ( P 〈0.005). Compared with the patient treated with≥6 chemotherapy cycles the recurrent rate of the patients with 1 - 5 chemotherapy cycles was higher ( P 〈 0.05). No significant difference of recurrence was observed between the patients with omental metastasis and without ( P 〉 0.05), unilateral primary tumor and bilateral ( P 〉 0.05). Conclusions Ovarian carcinoma mostly recur within 1 year and at pelvic. The recurrence is associated with clinical stage, histological differentiation, postoperative residual size and courses of regular chemotherapy.
出处 《中国妇产科临床杂志》 2006年第3期177-180,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 卵巢癌 化学疗法 复发 预后 ovarian carcinoma chemotherapy recurrence prognosis
  • 相关文献

参考文献7

二级参考文献21

  • 1李润春,王,张水湛.激光治疗植入性虹膜囊肿[J].中国实用眼科杂志,1996,14(10):634-635. 被引量:2
  • 2李孟达,黄欣.中、晚期卵巢癌综合治疗疗效及影响因素的分析[J].中华妇产科杂志,1996,31(10):621-623. 被引量:35
  • 3[3]Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta- analysis. J Clin Oncol, 2002, 20: 1248-1259.
  • 4[5]Eisenkop SM, Friedman RL, Wang HJ, et al. Complete cytoreductive surgery is feasible and msximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol, 1998,69:103 - 108.
  • 5[6]Morice P, Dubernard G, Rey A, et al. Results of interval debulking surgery in advanced stage ovarian cancer. J Am Coll Surg, 2003, 197:955 - 963.
  • 6[7]FanfaniF, Ferrandina G, Corrado G, et al. Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage Ⅲ c ovarian cancer patients. Oncology, 2003, 65: 316-322.
  • 7[8]Brun JL, Feyler A, Chene G, et al. Long- term results and prognostic factor in patients with epithelial ovarian cancer. Gynecol Oncol,2000, 78: 21-27.
  • 8Vrscaj MU, Rakar S. Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study [J]. Eur J Gynaecol Oncol,2002,23(5): 405- 410.
  • 9Hatae M, Onishi Y, Nakamura T, et al. Neoadjuvent chemotherapy for advanced epithelial cancer[J]. Gan To Kagaku Ryoho, 2001, 28(12): 1833 - 1837.
  • 10Rubin SC, Hoskins W J, Saigo PE, et al. Prognostic factors for recurrence following negative second-look laparoctomy in ovarian cancer patients treated with platinum-based chemotherapy[J]. Gynecol Oncol, 1991,42:137 -141.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部